Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1472 results

TAVI cases that I need to think more

18 May 2023 – From EuroPCR 2023

Consult this session if you want to optimise management of concomitant coronary artery disease and heart failure in TAVI patients, to predict, evaluate, and manage paravalvular leakage after TAVI, and to diagnose, manage, and prevent vascular complications in TAVI.

TAVI cases that I need to think more

Valve-in-valve procedures - Part 1

18 May 2023 – From EuroPCR 2023

Discover the innovative solutions offered by valve-in-valve procedures in this session: witness the successful application of this technique in a patient with heparin-induced thrombocytopenia, explore a captivating case series showcasing valve-in-valve TAVI in failed Perceval bioprostheses, delve into the complexities of TAVR in SAVR in IIIb type...

Valve-in-valve procedures - Part 1

TAVI 1: durability, mismatch and challenging anatomy

18 May 2023 – From EuroPCR 2023

Explore TAVI longevity: Five-year Portico valve outcomes, bioprosthetic dysfunction post-surgery or self-expanding TAVI, prosthesis-patient mismatch impact, and innovative valve-in-valve TAVI insights, and more.

TAVI 1: durability, mismatch and challenging anatomy

Shock with valve disease - Part 2

18 May 2023 – From EuroPCR 2023

In these slides, explore complex scenarios and complications of valve disease; from severe aortic regurgitatione to combined PCI and TAVI with ECMO support. Witness nightmare TAVI cases, the use of an urgent mitral clip, and many more.

Shock with valve disease - Part 2

SOLACI research - Developing original research across Latin America

17 May 2023 – From EuroPCR 2023

In these slides, get an insight into real-world bifurcation lesion management in Latin America, diverse STEMI reperfusion access in this region, and limitations to widespread TAVI adoption, along with the Latin America TAVI guidelines.

SOLACI research - Developing original research across Latin America

How to optimise TAVI pathway

17 May 2023 – From EuroPCR 2023

Consult this series of slides to enhance understanding on the TAVI pathway, get a defined idea of the role of a TAVI coordinator in patient journeys, and explore organisational dynamics in diverse TAVI centres.

How to optimise TAVI pathway

TAVI for bicuspid anatomy: beyond type I LR

17 May 2023 – From EuroPCR 2023

Consult this session if you want to understand the challenges of bicuspid aortic stenosis patients, type 0 in particular, to review contemporary sizing methods in bicuspid aortic stenosis, and to tailor the implant technique to individual patient.

TAVI for bicuspid anatomy:

Selecting the right first valve to secure lifetime management

17 May 2023 – From EuroPCR 2023

The treatment of young and less at-risk patients clearly shows that their age, life expectancy and risk factors are essential parameters to be taken into account in the choice of TAVI and therefore it is essential to think about future coronary access after TAVI. Watch the...

Selecting the right first

Cutting-edge technologies: clinical updates on TES, BRS, TAVR and LAA closure

17 May 2023 – From EuroPCR 2023

Watch this session to find out more about the three-year outcomes of the FUTURE-II Trial, the TARGET clinical trial roadmap, the TARGET IV NA Trial update, the twelve-month outcomes of the SAVE PROTECT Trial, and the quantitative aortographic assessment of regurgitation in patients treated with VitaFlow.

Cutting-edge technologies:

Long-term valve performance for the next decade and beyond

17 May 2023 – From EuroPCR 2023

How can TAVI outcomes be made better for younger patients with longer life horizons? Check-out in this session where you also will be able to gain in the understanding of the structural challenges of providing TAVI services and see how innovation can contribute to optimal outcomes and...

Long-term valve performance

Increase the complexity: multivalvular coronary interventions

17 May 2023 – From EuroPCR 2023

Investigate the increasing complexity of multivalvular coronary interventions in this insightful case-based presentation. Witness the complex challenges faced and discover the innovative approaches used to navigate the complex procedures.

Multivalvular coronary interventions

EuroPCR 2023 Hotlines/Late-Breaking Trials: TAVI, hypertension, stroke prevention

17 May 2023 – From EuroPCR 2023

Want to find out what's happened lately in the field of hypertension and stroke prevention with TAVI? Check out this session where speakers give their take on what's essential to remember from a selection of studies: Primary outcome of the AnchorMan LAAO device randomised controlled trial...

Trials summaries on TAVI, hypertension and stroke prevention

Challenging scenarios in STEMI and TAVI from Mexico

17 May 2023 – From EuroPCR 2023

This session looks at how to treat the following 3 types of cases: STEMI with MVD, AAA and TAVR, and late coronary obstruction after ViV TAVR. Analyze patients' conditions, consider the questions they raise, then find out about their final treatments.

Challenging scenarios in STEMI and TAVI from Mexico

Which valve for which patient? - Part 1: simple anatomy

17 May 2023 – From EuroPCR 2023

Explore this session to gain insights into the influence of valve design on hemodynamic performance and durability, understand its implications for risk factors associated with TAVI in bicuspid aortic valves, and grasp the relationship between valve design, implantation techniques, and the emergence of new conduction abnormalities...

Which valve for which patient? - Part 1: simple anatomy

Valve-in-valve - LIVE case

17 May 2023 – From EuroPCR 2023

Study the case of a 76-year-old female patient with BMI 32, atrial fibrillation, diabetes, mid chronic kidney disease and history of aortic stenosis, whose Perimount Magna Ease 21 (mismatch) surgical bioprosthesis, implanted in 2016, degenerated, with preserved left ventricular function. 

An Evolut Pro 26 was implanted in...

Valve-in-valve - LIVE case

Pitfalls during primary PCI in STEMI patients and TAVI procedure

17 May 2023 – From EuroPCR 2023

How should I treat? Explore this series of cases designed to enable you to gain knowledge of techniques for managing unexpected complications during primary PCI, tackle complex anatomical challenges with limited resources, encourage innovation and develop out-of-the-box solutions. In addition, discover effective lifesaving strategies to use...

Pitfalls during primary PCI in STEMI patients and TAVI procedure

Which valve for which patient? - Part 2: complex anatomy

17 May 2023 – From EuroPCR 2023

Consult this session if you want to understand how to optimize the hemodynamic performance after VinV procedures, to identify patients at risk for coronary occlusion and how to prevent this in VinV procedures, and to learn how to gain safe vascular access in challenging peripheral anatomies.

Which valve for which

Tailored device choice and implant technique to optimise TAVI procedural outcomes

17 May 2023 – From EuroPCR 2023

Discover the key factors to consider in selecting the optimal valve and implant technique for transcatheter aortic valve implantation (TAVI) to achieve optimal procedural outcomes. Gain insights into the impact of device choice and implantation technique on coronary access following TAVI and learn valuable strategies for...

Tailored device choice

Next generation balloon expandable TAVR and thin strut BRS - Science and clinical update

17 May 2023 – From EuroPCR 2023

Join this session for an update on the science and clinical advancements in next-generation balloon-expandable transcatheter aortic valve replacement (TAVR) and thin strut bioresorbable scaffolds (BRS). Discover how these innovative technologies can improve clinical outcomes by exploring case-based challenging scenarios and learn effective strategies for tackling...

Next generation balloon

Shock with valve disease - Part 1

17 May 2023 – From EuroPCR 2023

Discover here some compelling clinical cases on shock and valve disease. Experience real-life scenarios that will help you gain valuable knowledge and improve your clinical decision-making skills.

Shock and valve disease